Comprehensive search ChatGPT Online Scientific research tools Facebook Group Tools Telegram
Sign in Sign Up

Science Hub 每 Free Research Papers | Academic Community


[Springer] Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology

rx.etanol Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-02 03:24
Reward10points

A total of eight consensus statements were drafted. Myo-inositol (Myo) supplementation can be used to improve menses irregularities and anovulation in PCOS. Myo supplementation can be used in subfertile women with or without PCOS to reduce the dose of r-FSH for ovarian stimulation during IVF, but it should not be used to increase the clinical pregnancy rate or live birth rate. Myo supplementation can be used in the primary prevention of gestational diabetes mellitus (GDM), but should not be used to improve pregnancy outcomes in women with GDM. Myo can be preconceptionally added to folic acid in women with a previous neural tube defects (NTD)-complicated pregnancy to reduce the risk of NTDs in newborns. Myo can be used during pregnancy to reduce the risk of macrosomia and neonatal hypoglycemia in mothers at risk of GDM.

You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

Advanced Mode
B Color Image Link Quote Code Smilies
You have to log in before you can reply Login | Register

Points Rules

rx.etanol Lv.2
Junior Member

  • post

  • reply

  • points

    40

Same Category


Latest Reply

Announcement

Daily Top Contributors

Return to the list